ZAPPHIRE: A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis (clinicaltrials.gov) - Apr 9, 2026 - P2 | N=240 | Not yet recruiting | Sponsor: Chiesi Farmaceutici S.p.A.
New P2 trial • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
|